HYBRID EVENT: You can participate in person at Baltimore, MD, USA or Virtually from your home or work.

2nd Edition of International Conference on Gastroenterology

October 21-23, 2024, Baltimore, Maryland, USA

October 21 -23, 2024 | Baltimore, MD, USA

Gastro 2024

Speaker at Gastroenterology 2024 - Aleksandra Leszczynska
Keynote Presentation (In-Person)
Aleksandra Leszczynska, University of California San Diego, United States

Metabolic Dysfunction-Associated Steatohepatitis (MASH), a subset of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), has emerged as a significant public health concern worldwide. MASH is characterized by hepatic inflammation, which can lead to fibrosis, cirrhosi [....] » Read More

Speaker at Gastroenterology 2024 - Erika Johanna P Tanada
Oral Presentation (In-Person)
Erika Johanna P Tanada, University of Santo Tomas Hospital, Philippines

Menetrier’s disease is a rare, acquired premalignant disorder of the stomach with thickened gastric folds associated with protein-losing enteropathy and H Pylori infection. The clinical presentation of Menetrier’s disease might cause diagnostic difficulty and can be m [....] » Read More

Speaker at Gastroenterology 2024 - Omar Ahmed Alomair
Oral Presentation (In-Person)
Omar Ahmed Alomair, King Faisal University, Saudi Arabia

Background: Granular cell tumors (GCTs) are benign soft tissue tumors that are thought to originate from Schwann cells. They are relatively rare, and presentation in the gastrointestinal tract is even more uncommon. Case report: In this paper, we present a 26-year-old female p [....] » Read More

Speaker at Gastroenterology 2024 - Xueping Huang
Oral Presentation (In-Person)
Xueping Huang, Fujian Provincial Hospital, China

Background: The clinical application of bismuth quadruple therapy is often challenging due to the frequent adverse reactions and complicated administration of tetracycline and metronidazole. The aim of this study was to assess the efficacy, compliance, and safety of minocycline, [....] » Read More

Speaker at Gastroenterology 2024 - Junwei Zhang
Oral Presentation (In-Person)
Junwei Zhang, Peking Union Medical College Hospital, China

Background: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) was widely used in clinic. The mechanism of ALPPS need to be fully illustrated. Methods: The present systematic review aimed to examine existing data on the mechanism of ALPPS. Elec [....] » Read More

Speaker at Gastroenterology 2024 - Jinhua Hu
Oral Presentation (In-Person)
Jinhua Hu, Fifth Medical Center of Chinese PLA General Hospital, China

Liver regeneration is an ancient and realistic topic. The mechanism of liver regeneration is well described in the PHx model, and it is generally believed that multiple signaling pathways, including Wnt/β-Catenin signaling, Notch signaling, mTOR signaling, etc. are important [....] » Read More

Speaker at Gastroenterology 2024 - Zheng Jiang
Oral Presentation (In-Person)
Zheng Jiang, Chinese Academy of Medical Sciences and Peking Union Medical College, China

Background: Alternative splicing (AS) is an important transcriptional regulatory mechanism, leading to polymorphisms in transcript and protein structure and function. This study aimed to establish more accurate prediction models for nonmetastatic gastric cancer by AS. Methods: [....] » Read More

Speaker at Gastroenterology 2024 - Liu Qizhi
Oral Presentation (In-Person)
Liu Qizhi, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, China

D3 lymphadenectomy and Complete Mesocolic Excision (CME) are standard treatment for right colon cancer. Colon cancer of hepatic flexure is likely to have metastasis of the infrapyloric lymph nodes (No. 206), which are not regional Lymph Nodes (LN). LN dissection of No.206 group b [....] » Read More

Speaker at Gastroenterology 2024 - Sintayehu Fekadu
Oral Presentation (In-Person)
Sintayehu Fekadu, Hawassa University, Ethiopia

Epstein-Barr virus (EBV)-associated gastric cancer belongs to 1 of the 4 subtypes of gastric cancer and accounts for 10% of the total gastric cancers. However, most cases of gastric cancer have a history of Helicobacter pylori (H. pylori) infection. Therefore, we investigated t [....] » Read More

Speaker at Gastroenterology 2024 - Loyacono Nicolas
Oral Presentation (In-Person)
Loyacono Nicolas, Hospital de Clínicas José de San Martín, Argentina

Gastrointestinal, nutritional, metabolic, endocrine, and microbiota medical problems in pediatric patients diagnosed with autism spectrum disorder (ASD) are some of the coexisting medical conditions in ASD diagnosis. Their prevalence reaches more than 91 % for gastrointestinal pr [....] » Read More

Speaker at Gastroenterology 2024 - Kristiann Lae Dano
Oral Presentation (In-Person)
Kristiann Lae Dano, Davao Regional Medical Center, Philippines

Introduction: Pancreatic Tuberculosis is considered a rare extrapulmonary source of Tuberculosis even on highly prevalent countries. The diagnosis can be challenging since the signs and symptoms can mimic pancreatic cancer. With the patient’s consent, this case report will [....] » Read More

Speaker at Gastroenterology 2024 - Mohamed Eraki
Oral Presentation (In-Person)
Mohamed Eraki, Zagazig University, Egypt

Ischemic colitis is rarely treated by laparoscopy. The point of this review using of propensity score matched study to compare preoperative with intraoperative character and short-term outcome for severe and urgent cases of ischemic colitis. Methods techniques:&nb [....] » Read More

Speaker at Gastroenterology 2024 - Nosherwan Shahwani
Oral Presentation (In-Person)
Nosherwan Shahwani, Liaquat National hospital, Pakistan

INTRODUCTION: The pancreaticobiliary diseases are common in the elderly. The prevalence of choledocholithiasis (bile duct stones) increases with age about four times compared with the younger population Endoscopic retrograde cholangiopancreatography (ERCP) is a routinely used di [....] » Read More

Speaker at Gastroenterology 2024 - Kanwal Butani
Oral Presentation (In-Person)
Kanwal Butani, Jinnah Postgraduate Medical Center, Pakistan

Introduction: Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common Chronic Liver Disease (CLD).  NAFLD is recognized as an important public health problem nowadays and it encompasses a variety of liver pathologies including simple steatosis, Nonalcoholic Steatohepati [....] » Read More

Speaker at Gastroenterology 2024 - Lana Aleuy
Poster Presentation (In-Person)
Lana Aleuy, Emory University School of Medicine, United States

Background: Nausea and vomiting are common presenting complaints; patients usually receive antiemetics and are discharged once able to tolerate oral intake. Etiology is usually unknown. Sometimes, diagnosis requires a more thorough workup, and treatment is not always gastroent [....] » Read More

Speaker at Gastroenterology 2024 - Michelle Dawn Ramos
Poster Presentation (In-Person)
Michelle Dawn Ramos, Chong Hua Hospital, Philippines

Pancreatic lipomatosis is a rare disease with an unknown etiology characterized by the replacement of pancreatic acinar cells with adipose tissue associated with preservation of pancreatic duct and islet cell histology. In this paper, we report the case of two 40- and 46-year- [....] » Read More

Speaker at Gastroenterology 2024 - Katrina Nicole R. Mejia
Poster Presentation (In-Person)
Katrina Nicole R. Mejia, Cardinal Santos Medical Center, Philippines

Malignant melanoma is most commonly found on the skin and rarely occurs in the the rectal region. We report a case of a 77-year-old Filipino adult presenting with rectal bleeding for three weeks. He underwent sigmoidoscopy that showed thrombosed hemorrhoids; however, subsequent s [....] » Read More

Speaker at Gastroenterology 2024 - Celyn Idami
Poster Presentation (In-Person)
Celyn Idami, Penn Medicine, United States

First approved in the United States in 2011, immune checkpoint inhibitors (ICIs) represent a significant advancement in treating various malignancies. The mechanism of action is to prevent inhibition of the host's T cells, thereby allowing them to attack and destroy malignant [....] » Read More

Speaker at Gastroenterology 2024 - William Song
Poster Presentation (In-Person)
William Song, Ochsner Clinic Foundation, United States

Gastric cancer is the 5th most common type of malignancy world-wide. Obesity has been associated with an increased risk of gastric cancer and Roux-en-Y is the most commonly performed surgical weight-loss procedure in the US. Gastric adenocarcinoma in the remnant stomach after Rou [....] » Read More

Speaker at Gastroenterology 2024 - Eman Mohamad EL Nashar
Poster Presentation (In-Person)
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia

Stress-induced gastritis is a common problem in the intensive care unit. Zeaxanthin (ZE), a non-provitamin A carotenoid has been known to exert antioxidant and anti-inflammatory effects. In this study, we examined the effect of ZE on water avoidance stress (WAS)-induced gastritis [....] » Read More

Speaker at Gastroenterology 2024 - Eman Mohamad EL Nashar
Poster Presentation (In-Person)
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia

Autophagy is a key metabolic process where cells can recycle its proteins and organelles to regenerate its own cellular building blocks. Chemotherapy is indispensable for cancer treatment but associated with various side-effects, including organ damage. Stem cell-based therapy is [....] » Read More

Speaker at Gastroenterology 2024 - Lin Lv
Poster Presentation (In-Person)
Lin Lv, Chongqing medical university, China

Aims: Ulcerative colitis (UC) is a chronic recurrent non-specific inflammatory disease, and the pathogenesis of the disease is remaining unclear. Ferroptosis is a form of programmed cell death characterized by accumulation of iron-dependent lipid peroxides that are simultaneously [....] » Read More

Speaker at Gastroenterology 2024 - Orestis Ioannidis
Keynote Presentation (Virtual)
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece

Cholelithiasis presents in approximately 20 % of the total population, ranging between 10% and 30 %. It presents one of the most common causes for non malignant surgical treatment. The cornerstone therapy is laparoscopic cholecystectomy, urgent of elective. Laparoscopic cholecyst [....] » Read More

Speaker at Gastroenterology 2024 - Brandon Lucke Wold
Keynote Presentation (Virtual)
Brandon Lucke Wold, University of Florida, United States

Neurologic injury often influences various bodily functions associated with digestion. It is imperative for an individual to obtain proper nutrients to maintain a healthy lifestyle and recover from injury. In this review, we explore variables and methods of enteral tube placement [....] » Read More

Speaker at Gastroenterology 2024 - Maria Isabel Torres Lopez
Keynote Presentation (Virtual)
Maria Isabel Torres Lopez, University of Jaen, Spain

Celiac Disease  (CD) is an autoimmune condition resulting from gluten sensitivity in genetically predisposed individuals. It is a multifactorial disorder in which genetic, environmental, and immunological factors converge to determine the gluten sensitivity observed in affec [....] » Read More

Speaker at Gastroenterology 2024 - Tomasz Tabernacki
Oral Presentation (Virtual)
Tomasz Tabernacki, Case Western Reserve University School of Medicine, United States

Significance: Gender-Affirming Hormone Therapy (GAHT) plays a vital role in gender identity affirmation for transgender individuals. While hormonal profiles after GAHT may differ from cisgender individuals, the impact of GAHT on gallbladder disease risk in transgender population [....] » Read More

Speaker at Gastroenterology 2024 - Orestis Ioannidis
Oral Presentation (Virtual)
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece

Acute peritonitis is a relatively common intra-abdominal infection that a general surgeon will have to manage many times in his surgical carrier. Usually it is a secondary peritonitis caused either by direct peritoneal invasion from an inflamed infected viscera or by gastrointest [....] » Read More

Speaker at Gastroenterology 2024 - Dakota Bigham
Oral Presentation (Virtual)
Dakota Bigham, The University of Texas Health Science Center- San Antonio, United States

Introduction: Colorectal carcinoma (CRC) is the third most common cancer and the second leading cause of cancer-related deaths in the US. Classic manifestations of CRC include rectal hemorrhage, unintentional weight loss, abdominal discomfort, and changes in bowel habits, w [....] » Read More

Speaker at Gastroenterology 2024 - Nancy Brulinska
Oral Presentation (Virtual)
Nancy Brulinska, University Hospital Limerick, Ireland

Background: Actinomycosis is a bacterial infection caused by Gram positive, non-acid fast, anaerobic or microacrophilic rods. Actinomycetes can be found in the normal flora of the oral cavity, as well as less commonly in the lower GIT and female genital tract but are not virulen [....] » Read More

Speaker at Gastroenterology 2024 - Rui Gao
Oral Presentation (Virtual)
Rui Gao, Fujian Provincial Hospital, China

Background: Gastric dysplasia is not only a precancerous lesion, but also a neoplastic lesion. Although the relationship between gastric intestinal metaplasia (IM) and gastric cancer is currently controversial, gastric dysplasia can be detected in intestinal metaplastic glands. I [....] » Read More

Speaker at Gastroenterology 2024 - Jinfeng Zhou
Oral Presentation (Virtual)
Jinfeng Zhou, The Second Affiliated Hospital of Southern University of Science and Technology, China

Abstract:  Endoscopic Submucosal Excavation (ESE) has been successfully applied to the resection of gastric Submucosal Tumors (SMTs), but rarely to colon SMTs duo to the inevitable perforation and subsequent peritonitis. The perforation is usually difficult to be closed in s [....] » Read More

Speaker at Gastroenterology 2024 - Perry Hookman
Oral Presentation (Virtual)
Perry Hookman, Light of the World Free Clinic, United States

Colon perforation has been reported as caused by trauma, e.g., colonoscope perforation, malignancy, infection, amoebic colitis, diverticular disease, as well as spontaneous perforation, with ulcerative colitis. A not well-known  cause is  congenital Hirschsprung’s [....] » Read More

Speaker at Gastroenterology 2024 - Taherah Mohammadabadi
Oral Presentation (Virtual)
Taherah Mohammadabadi, Agricultural Sciences and Natural Resources University, Iran (Islamic Republic of)

Nowadays, the researchers following some adjunctive natural healings for gastro-Intestinal issues. Due to the side effects and temporary impacts of chemical drugs, the use of herbal drugs as a complementary drug along with chemical drugs is recommended for gastrointestinal and [....] » Read More

Speaker at Gastroenterology 2024 - Wei Qiu
Poster Presentation (In-Person)
Wei Qiu, Loyola University Chicago, United States

Alcohol-asscociated liver disease (ALD) represents a spectrum of alcohol use-related diseases, ranging from steatosis to cirrhosis, and is one of the primary causes of chronic liver disease worldwide.  Outside of alcohol abstinence, there are currently no FDA-approved treatm [....] » Read More

Speaker at Gastroenterology 2024 - Marjorie M. Rooney
Poster Presentation (Virtual)
Marjorie M. Rooney, Oklahoma State University Center for Health Sciences, United States

Introduction: Gastritis is a general form of upper abdominal pain. With its high frequency and the copious non-surgical and surgical treatment options, we believe patients are likely searching the internet for questions applicable to gastritis. No investigation has ever been c [....] » Read More

Speaker at Gastroenterology 2024 - Ying Yang
Poster Presentation (Virtual)
Ying Yang, Key Laboratory for Diagnosis and Treatment of Infectious Diseases, China

Will be Updated Soon...

Speaker at Gastroenterology 2024 - Vinay
Poster Presentation (Virtual)
Vinay, Southampton Interventional Endoscopy Unit, United Kingdom

Achalasia is treated most effectively by Peroral Endoscopic Myotomy (POEM), Laparoscopic Heller’s myotomy (LHM), Balloon Dilation (BD) or Botox therapy. This retrospective study compared treatment modalities of these four treatments at UHS, a tertiary referral centre for ac [....] » Read More

Speaker at Gastroenterology 2024 - Javokhir Jaloljon Qochqarov
Poster Presentation (Virtual)
Javokhir Jaloljon Qochqarov , Tashkent Medical Academy , Uzbekistan

Introduction: Gastritis is an inflammatory or dystrophic change that occurs in the mucous membrane of the stomach. The disease leads to a breakdown of the functions of these organs, as well as the development of atrophy of the epithelial cells, resulting in the formation of repla [....] » Read More